Novacyt (NCYT) EUR0.0667 (CDI)
Share news, reports & tips
13 July 2020 09:08
(Sharecast News) - Clinical diagnostics group Novacyt said first-half revenues surged as demand for its Covid-19 testing kit was expected to continue into 2021.
18 June 2020 09:33
(Sharecast News) - Clinical diagnostics firm Novacyt launched three new products aimed at supporting laboratories testing for Covid-19 on Thursday.
3 June 2020 12:28
(Sharecast News) - Clinical diagnostics company Novacyt will settle all outstanding debt obligations with Harbert European Growth Capital (HEGC) and Vatel Capital, it announced on Wednesday.
2 June 2020 09:05
(Sharecast News) - Clinical diagnostics firm Novacyt secured more contract wins for its Primerdesign Covid-19 detection test, but also cautioned that it had suffered a slight setback in France.
29 April 2020 12:43
(Sharecast News) - Novacyt said on Wednesday that its subsidiary Primerdesign has sold, received orders for or has been contracted to deliver more than ?90m of its Covid-19 test.
27 April 2020 09:49
(Sharecast News) - Healthcare company Novacyt said it had signed a contract with the UK Department of Health to supply its Covid-19 polymerase chain reaction test.
8 April 2020 11:16
(Sharecast News) - Biotech group Novacyt said its Covid-19 diagnostic test had been deemed eligible for procurement under the World Health Organisation's Emergency Use Listing process.
25 March 2020 14:50
(Sharecast News) - Clinical diagnostics company Novacyt announced on Wednesday that it has signed an agreement for certain contract manufacturing services with molecular diagnostics firm Yourgene Health.
23 March 2020 09:54
(Sharecast News) - Novacyt said on Monday that the US Food and Drug Administration has issued an emergency use authorisation for its Covid-19 test.
16 March 2020 09:46
(Sharecast News) - Novacyt said on Monday that Public Health England has decided to use a Covid-19 test developed by its molecular diagnostics division, Primerdesign.
12 March 2020 12:27
(Sharecast News) - Clinical diagnostics company Novacyt updated the market on its Covid-19 coronavirus test, developed by its molecular diagnostics division Primerdesign, on Thursday.
28 February 2020 09:52
(Sharecast News) - Clinical diagnostics company Novacyt updated the market on its novel Covid-19 coronavirus test developed by its molecular diagnostics division Primerdesign on Friday.
Company announcements Announcements
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2020. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.